US Archives - Page 63 of 129 - European Medical Journal

Phase III Lung Cancer Trial Terminated Due to Futility

A major phase 3 lung cancer trial investigating the TGIT-targeting immunotherapy ociperlimab has been halted after interim analysis indicated it would not meet its primary endpoint of overall survival.

Luteal Phase Heightens Avoidance Responses

The menstrual cycle significantly impacts women’s emotional decision-making and cognitive processing, according to a new EEG study examining approach-avoidance behaviors across different hormonal phases.

Call for Nationwide Overhaul of Newborn Cystic Fibrosis Screening

In a significant development for U.S. healthcare, new consensus guidelines from the Cystic Fibrosis Foundation call for a nationwide overhaul of newborn screening protocols for cystic fibrosis (CF).

U.S. H5N1 Bird Flu Outbreaks: Key Trends and Updates

The highly pathogenic avian influenza virus H5N1, commonly known as bird flu, is rapidly evolving in the United States, spreading beyond migratory birds to affect mammals and, most recently, dairy cattle.

From Bench to Bedside: Keith Choate

If you look closely at the fundamental discoveries that have changed human health, physician–scientists have been at the center of the great majority.

Exploring the Effects of Nutrition on Juvenile Arthritis: One-Year Study Results

A new study examining the long-term effects of a specific carbohydrate diet (SCD) in children with juvenile idiopathic arthritis (JIA) suggests potential benefits, particularly for individuals seeking to avoid medication escalation.

Excessive Heat Prevention Leads to Better Rhinophyma Outcomes

A novel combination of rhinoshave and fractional ablative CO2 laser therapy is proving to be a safe and effective approach for treating pronounced rhinophyma, offering precise contouring with minimal complications and high patient satisfaction, according to a new study.

Real-World Use of Bimekizumab Therapy for Difficult-to-Treat Plaque Psoriasis

Discover a new study from a large academic center that supports bimekizumab as an effective treatment for moderate-to-severe plaque psoriasis.

Moderate Alcohol Consumption Linked to Alzheimer's Biomarkers in New Study

Light-to-moderate alcohol consumption may contribute to increased amyloid beta (Aβ) deposition, a hallmark biomarker of Alzheimer’s disease, according to new findings from the ALBION study.

Investigating FDA Reports of Tirzepatide-Thyroid Cancer Connection

The rapid rise in prescriptions for GLP-1 receptor agonists, including tirzepatide (Mounjaro) and semaglutide (Ozempic; Lilly, Indianapolis, Indiana, USA), has sparked concerns about potential long-term safety risks.